|
|
|
Suzhou Lixinpharmaceutical Co., Ltd.
|
|
| |
|
|
|
|

|

|
Click to enlarge image
|
Model Number |
BP2007,USP31,EP6th |
|
Acrivastine
|
|
[ Product introduction ]
|
Treatment for allergic skin disorders, allergic rhinitis, upper respiratory tract disorders, urticaria. Histamine H1 Antagonists
|
|
[ Structural formula ]
|

|
| [ C A S ] |
87848-99-5 |
| [ Chemical name ] |
(E)-3-[6-[(E)-1-(4-Methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridin-2-yl]prop-2-enoicacid |
| [ Molecular formula ] |
C22H24N2O2 |
| [ Molecular weight ] |
348.44 |
| [ Property ] |
White-like needle crystal or crystalline powder; odorless, flavorless, easily soluble in acetone, glacial acetic acid, soluble in ethanol or ethyl acetate, slightly soluble in chloroform or ether, insoluble in water or diluted hydrochloric acid. |
| [ Packing specification ] |
5Kg / tin, 25Kg / pail |
| [ Storage ] |
Sealed and stored at room temperature. |
| [ Executive standard ] |
BP2007,USP31,EP6th |
| [ Main index ] |
White-like needle crystal or crystalline powder; odorless, melting ptoint:220℃~222℃ Content(HPLC):>99%
|
|
[ Quality standard ]
|
Purity (HPLC): >98% Appearance: gray white to white powdery solid Loss on dry: <0.5% Moisture: <0.5% Melting point: >250°C
|
|
|
Supply ability |
100kg per year |
|
|
| |
|
|
|